MYC and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: However, if overexpression of PEG10 is associated with up-regulation of c-Myc in PACa, c-Myc inhibition may be a therapeutic option for the subset of PACa patients with a poor prognosis and overexpression of PEG10.